Skip to main content
SpringerLink
Log in

The Characterization, Stabilization, and Formulation of Acidic Fibroblast Growth Factor

  • Chapter
Formulation, Characterization, and Stability of Protein Drugs: Case Histories

Part of the book series: Pharmaceutical Biotechnology ((PBIO,volume 9))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Ago, H., Kitagawa, Y., Fujishima, A., Matsuura, Y., and Katsube, Y., 1991, Crystal structure of basic fibroblast growth factor at 1.6 A resolution, J. Biochem. 110:360–363.

    Article  CAS  PubMed  Google Scholar 

  • Ahern, T. J., and Manning, M. C. (eds.), 1992, Stability of Protein Pharmaceutical. Part A. Chemical and Physical Pathways of Protein Degradation, Plenum Press, New York.

    Google Scholar 

  • Arakawa, T., Horan, T. P., Narhi, L. O., Rees, D. C., Schiffer, S. G., Hoist, P. L., Prestrelski, S. J., Tsai, L. B., and Fox, G. M., 1993, Production and characterization of an analog of acidic fibroblast growth factor with enhanced stability and biological activity, Protein Eng. 6:541–546.

    Article  CAS  PubMed  Google Scholar 

  • Aviezer, D., Levy, E., Safran, M., Svahn, C., Buddecke, E., Schmidt, A., David, G., Vlodavsky, I., and Yayon, A., 1994, Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor, J. Biol. Chem. 269:114–121.

    CAS  PubMed  Google Scholar 

  • Bondi, J., Henley, M. W., and Matuszewska, B., 1992, Lyophilized acidic fibroblast growth factor. European Patent Application 92309544.2.

    Google Scholar 

  • Burgess, W. H., 1991, Structure-function studies of acidic fibroblast growth factor, Ann. N.Y. Acad. Sci. 638:89–97.

    Article  CAS  PubMed  Google Scholar 

  • Burgess, W. H., and Macaig, T., 1989, The heparin-binding (fibroblast) growth factor family of proteins, Ann. Rev. Biochem. 58:575–606.

    Article  CAS  PubMed  Google Scholar 

  • Burgess, W. H., Shaheen, A. M., Hampton, B., Donohue, P. J., and Winkles, J. A., 1991, Structure-function studies of heparin-binding (acidic fibroblast) growth factor-1 using site-directed mutagenesis, J. Cell. Biochem. 45:131–138.

    Article  CAS  PubMed  Google Scholar 

  • Burke, C. J., Steadman, B. L., Volkin, D. B., Tsai, P. K., Bruner, M. W., and Middaugh, C. R., 1992, The adsorption of proteins to container surfaces, Int. J. Pharm. 86:89–93.

    Article  CAS  Google Scholar 

  • Burke, C. J., Volkin, D. B., Mach, H., and Middaugh, C. R., 1993, Effect of polyanions on the unfolding of acidic fibroblast growth factor, Biochemistry 32:6419–6426.

    Article  CAS  PubMed  Google Scholar 

  • Castellot, Jr., J. J., Choay, J. Lormeau, J. C., Petitou, M., Sache, E., and Karnovsky, M. J., 1986, Structural determinants of the capacity of heparin to inhibit the proliferation of vascular smooth muscles. II. Evidence for a pentasaccharide sequence that contains a 3-O-sulfate group, J. Cell Biol. 102:1979–1984.

    Article  CAS  PubMed  Google Scholar 

  • Chavan, A. J., Haley, B. E., Volkin, D. B., Marfia, K. E., Verticelli, A. M., Bruner, M. W., Draper, J. P., Burke, C. J., and Middaugh, C. R., 1994, Interactions of nucleotides with acidic fibroblast growth factor (FGF-1), Biochemistry 33:7193–7202.

    Article  CAS  PubMed  Google Scholar 

  • Chen, B.-L., Arakawa, T., Morris, C. F, Kenney, W. C., Wells, C. M., and Pitt, C. G., 1994, Aggregation pathway of recombinant human keratinocyte growth factor and its stabilization, Pharm. Res. 11:1581–1587.

    Article  CAS  PubMed  Google Scholar 

  • Clarke, S., Stephenson, R. C., and Lowenson, J. D., 1992, Lability of asparagine and aspartic acid residues in proteins and peptides, in: Stability of Protein Pharmaceuticals. Part A. Chemical and Physical Pathways of Protein Degradation (T. J. Ahern and M. C. Manning, eds.), Plenum Press, New York, pp. 1–29.

    Google Scholar 

  • Cleland, J. and Langer, R. (eds.), 1994, Formulation and Delivery of Proteins and Peptides, American Chemical Society, Washington, DC.

    Google Scholar 

  • Copeland, R. A., Ji, H., Halfpenny, A. J., Williams, R. W., Thompson, K. C., Herber, W. K., Thomas, K. A., Bruner, M. W., Ryan, J. A., Marquis-Omer, D., Sanyal, G., Sitrin, R. D., Yamazaki, S., and Middaugh, C. R., 1991, The structure of human acidic fibroblast growth factor and its interaction with heparin, Arch. Biochem. Biophys. 289:53–61.

    Article  CAS  PubMed  Google Scholar 

  • Dabora, J. M., Sanyal, G., and Middaugh, C. R., 1991, Effects of polyanions on the refolding of human acidic fibroblast growth factor, J. Biol. Chem. 266:23637–23640.

    CAS  PubMed  Google Scholar 

  • Edelman, E. R., Mathiowitz, E., Langer, R., and Klagsbrun, M., 1991, Controlled and modulated release of basic fibroblast growth factor, Biomaterials 12:619–626.

    Article  CAS  PubMed  Google Scholar 

  • Engleka, K. A., and Maciag, T., 1992, Inactivation of human fibroblast growth factor-1 (FGF-1) activity by interaction with copper ions involves FGF-1 dimer formation induced by copper-catalyzed oxidation, J. Biol. Chem. 267:11307–11315.

    CAS  PubMed  Google Scholar 

  • Eriksson, A. E., Cousens, L. S., and Matthews, B. W., 1993, Refinement of the structure of human basic fibroblast growth factor at 1.6 A resolution and analysis of presumed heparin binding sites by selenate substitution, Protein Sci. 2:1274–1284.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Eriksson, A. E., Cousens, L. S., Weaver, L. H., and Matthews, B. W., 1991, Three-dimensional structure of human basic fibroblast growth factor, Proc. Natl. Acad. Sci. USA 88:3441–3445.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Finetti, G., and Farina, M., 1992, Recombinant human basic fibroblast growth factor: different medical dressings for clinical application in wound healing, IL Farmaco 47:967–978.

    CAS  PubMed  Google Scholar 

  • Folkman, J., Szabo, S., Strovroff, M,, McNeil, P., Li, W., and Shing, Y, 1991, Duodenal ulcer. Discovery of a new mechanism and development of angiogenic therapy that accelerates healing, Ann. Surg. 214: 414–427.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Giardino, I., Edelstein, D., and Brownlee, M., 1994, Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity: A model for intracellular glycosylation in diabetes, J. Clin. Invest. 94:110–117.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Greenhalgh, D. G., Strugel, K. H., Murray, M. J., and Ross, R., 1990, PDGF and FGF stimulate wound healing in the genetically diabetic mouse, Am. J. Pathol. 163:1235–1246.

    Google Scholar 

  • Harper, J. W., and Lobb, Roy R., 1988, Reductive methylation of lysine residues in acidic fibroblastgrowth factor: Effect on mitogenic activity and heparin affinity, Biochemistry 27:671–678.

    Article  CAS  PubMed  Google Scholar 

  • Jans, D. A., 1994, Nuclear signaling pathways for polypeptide ligands and their membrane receptors?, FASEB J. 8:841–847.

    CAS  PubMed  Google Scholar 

  • Kan, M, Wang, F, Xu, J., Crabb, J. W., Hon, J., and McKeehan, W. L., 1993, An essential heparin-binding domain in the fibroblast growth factor receptor kinase, Science 259:1918–1921.

    Article  CAS  PubMed  Google Scholar 

  • Li, L.-Y., Safran, M., Aviezer, D., Böhlen, P., Seddon, A. P., and Yayon, A., 1994, Diminished heparin binding of a basic fibroblast growth factor mutant is associated with reduced receptor binding, mitogenesis, plasminogen activator induction, and in vitro angiogenesis, Biochemistry 33:10999–11007.

    Article  CAS  PubMed  Google Scholar 

  • Linemeyer, D. L., Menke, J. G., Kelly, L. J., DiSalvo, J., Soderman, D., Schaeffer, M.-T., Ortega, S., Gimenez-Gallego, G., and Thomas, K. A., 1990, Disulfide bonds are neither required, present, nor compatible with full activity of human recombinant acidic fibroblast growth factor, Growth Factors 3:287–298.

    Article  CAS  PubMed  Google Scholar 

  • Linhardt, R. J., 1991, Heparin: an important drug enters its seventh decade, Chem. Ind. 21:45–50.

    Google Scholar 

  • Mach, H., Burke, C. J., Volkin, D. B., Dabora, J. M., Sanyal, G., and Middaugh, C. R., 1992, Effect of polyanions on the folding and unfolding of acidic fibroblast growth factor, in: Harnessing Biotechnology for the 21st Century (M.R. Ladish and A. Bose, eds.), American Chemical Society, Washington, DC, pp. 290–293.

    Google Scholar 

  • Mach, H., and Middaugh, C. R., 1994, Probing protein-ligand affinity by unfolding kinetics: Interaction of acidic fibroblast growth factor with polyanions. Arch. Biochem. Biophys. 309:36–42.

    Article  CAS  PubMed  Google Scholar 

  • Mach, H., and Middaugh, C. R., 1995, Interaction of partially unfolded states of acidic fibroblast growth factor with phospholipid membranes, Biochemistry, in press.

    Google Scholar 

  • Mach, H., Ryan, J. A., Burke, C. J., Volkin, D. B., and Middaugh, C. R., 1993b, Partially structured self-associating states of acidic fibroblast growth factor, Biochemistry 32:7703–7711.

    Article  CAS  PubMed  Google Scholar 

  • Mach, H., Volkin, D. B., Burke, C. J., Middaugh, C. R., Linhardt, R. J., Fromm, J. R., Loganathan, D., and Mattsson, L., 1993, Nature of the interaction of heparin with acidic fibroblast growth factor, Biochemistry 32:5480–5489.

    Article  CAS  PubMed  Google Scholar 

  • Marks, M. G., Doillon, C., and Silver, F. H., 1991, Effect of fibroblasts and basic fibroblast growth factor on facilitation of dermal wound healing by type I collagen matrices, J. Biomed. Mater. Res. 25: 683–696.

    Article  CAS  PubMed  Google Scholar 

  • Matuszewska, B., Keogan, M., Fisher, D. M., Soper, K. A., Hoe, C. M., Huber, A. C., and Bondi, J. V, 1994, Acidic fibroblast growth factor: evaluation of topical formulations in a diabetic mouse wound healing model, Pharm. Res. 11:65–71.

    Article  CAS  PubMed  Google Scholar 

  • McKeehan, W.L., and Kan, M., 1994, Heparan sulfate fibroblast growth factor receptor complex; structure-function relationships, Mol Reprod. Dev. 39:69–82.

    Article  CAS  PubMed  Google Scholar 

  • McPherson, J. M., 1992, The utility of collagen-based vehicles in delivery of growth factors for hard and soft tissue wound repair, Clin. Mater. 9:225–234.

    Article  CAS  PubMed  Google Scholar 

  • Mellin, T. N., Cashen, D. E., Ronan, J. J., Murphy, B. S., DiSalvo, J., and Thomas, K. A., 1995, Acidic fibroblast growth factor accelerates dermal wound healing in diabetic mice, J. Invest. Dermatol. 104:850–855.

    Article  CAS  PubMed  Google Scholar 

  • Middaugh, C. R., Mach, H., Burke, C. J., Volkin, D. B., Dabora, J. M., Tsai, P. K., Bruner, M. W., Ryan, J. A., and Marfia, K. E., 1992, Molecular basis of the anti-growth factor activity of suramin, Biochemistry 31:9016–9024.

    Article  CAS  PubMed  Google Scholar 

  • Middaugh, C. R., Volkin, D. B., and Thomas, K. A., 1993, Acidic and basic fibroblast growth factor, Curr. Opin. Invest. Drugs 2:991–1005.

    Google Scholar 

  • Nachtmann, F., Atzl, G., and Roth, W. D., 1983, Heparin sodium, in: Analytical Profiles of Drug Substances, Vol. 12 (K. Florey, ed.), Academic Press, pp. 215–263.

    Google Scholar 

  • Ornitz, D. M., Yayon, A., Flanagan, J. G., Svahn, C. M., Levi, E., and Leder, P., 1992, Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells, Mol. Cell. Biol. 12:240–247.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ortega, S., Schaeffer, M.-T., Soderman, D., DiSalvo, J., Linemeyer, D. L., Gimenez-Gallego, G., and Thomas, K. A., 1991, Conversion of cysteine to serine residues alters the activity, stability, and heparin dependence of acidic fibroblast growth factor, J. Biol Chem. 266:5842–5846.

    CAS  PubMed  Google Scholar 

  • Pantoliano, M. W., Horlick, R. A., Springer, B. A., Van Dyk, D. E., Tobery, T., Wetmore, D. R., Lear, J. D., Nahapetian, A. T, Bradley, J. D., and Sisk, W. P., 1994, Multivalent ligand-receptor binding interactions in the fibroblast growth factor system produce a cooperative growth factor and heparin mechanism for receptor dimerization, Biochemistry 33:10229–10248.

    Article  CAS  PubMed  Google Scholar 

  • Pineda-Lucena, A., Jimenez, M. A., Nieto, J. L., Santoro, J., Rico, M, and Gimenez-Gallego, G., 1994, 1H-NMR assignment and solution structure of human acidic fibroblast growth factor activated by inositol hexasulfate, J. Mol. Biol. 242:81–98.

    Article  CAS  PubMed  Google Scholar 

  • Pineda-Lucena, A., Núũnez De Castro, I., Lozano, R. M., Munoz-Willery, I., Zazo, M., and Gimenez-Gallego, G., 1994, Effect of low pH and heparin on the structure of acidic fibroblast growth factor, Eur. J. Biochem. 222:425–431.

    Article  CAS  PubMed  Google Scholar 

  • Rosenblum, S. F., Frenkel, S., Ricci, J. R., and Alexander, H., 1993, Diffusion of fibroblast growth factor from a plaster of paris carrier, J. Appl. Biomater. 4:67–72.

    Article  CAS  PubMed  Google Scholar 

  • Tefft, J., Roskos, K. V., and Heller, J., 1992, Development of hydrogel containing stabilized basic fibroblast growth factors for wound treatment, Proc. Int. Symp. Control. Rel. Bioact. Mater. 19:371–372.

    Google Scholar 

  • Thompson, L. D., Pantoliano, M. W., and Springer, B. A., 1994, Energetic characterization of the basic fibroblast growth factor-heparin interaction: Identification of the heparin binding domain, Biochemistry 33:3831–3840.

    Article  CAS  PubMed  Google Scholar 

  • Tsai, P. K., Volkin, D. B., Dabora, J. M., Thompson, K. C., Bruner, M. W., Cress, J. O., Matuszewska, B., Keogan, M., Bondi, J. V., and Middaugh, C. R., 1993, Formulation design of an acidic fibroblast growth factor, Pharm. Res. 10:649–659.

    Article  CAS  PubMed  Google Scholar 

  • Volkin, D. B., and Klibanov, A. M., 1989, Minimizing protein inactivation, in: Protein Function: A Practical Approach (T.E. Creighton, ed.), Oxford Press, Oxford, England, pp. 1–24.

    Google Scholar 

  • Volkin, D. B., and Middaugh, C. R., 1992, The effect ot temperature on protein structure, in: Stability of Protein Pharmaceuticals. Part A. Chemical and Physical Pathways of Protein Degradation (T. M. Ahern and M. C. Manning, eds.), Plenum Press, New York, pp. 215–247.

    Google Scholar 

  • Volkin, D. B., Tsai, P. K., Dabora, J. M., Gress, J. O., Burke, C. J., Linhardt, R. J., and Middaugh, C. R., 1993a, Physical stabilization of acidic fibroblast growth factor by polyanions. Arch. Biochem. Biophys. 300:30–41.

    Article  CAS  PubMed  Google Scholar 

  • Volkin, D. B., Tsai, P. K., Dabora, J. M., and Middaugh, C. R., 1991, The effect of polyanions on the stabilization of acidic fibroblast growth factor, in: Harnessing Biotechnology for the 21st Century (M.R. Ladish and A. Bose, eds.), American Chemical Society, Washington, DC, pp. 298–302.

    Google Scholar 

  • Volkin, D. B., Verticelli, A. M., Bruner, M. W., Marfia, K. E., Tsai, P. K., Sardana, M. K., and Middaugh, C. R., 1995, Deamidation of polyanion-stabilized acidic fibroblast growth factor, J. Pharm. Sci. 84:7–11.

    Article  CAS  PubMed  Google Scholar 

  • Volkin, D. B., Verticelli, A. M., Marfia, K. E., Burke, C. J., Mach, H., and Middaugh, C. R., 1993b, Sucraltate and soluble sucrose octasulfate bind and stabilize acidic fibroblast growth factor, Biochim. Biophys. Acta 1203:18–26.

    Article  CAS  PubMed  Google Scholar 

  • Walker, A., Turnbull, J. E., and Gallagher, J. T., 1994, Specific heparan sulfate saccharides mediate the activity of basic fibroblast growth factor. Biochemistry 33:10229–10248.

    Article  Google Scholar 

  • Wang, Y. J., and Pearlman, R., 1992, Stability and Characterization of Protein Drugs: Case Histories I, Plenum Press, New York.

    Google Scholar 

  • Wiedlocha, A., Madshus, I. H., Mach, H., Middaugh, C. R., and Olsnes, S., 1992, Tight folding of acidic fibroblast growth factor prevents its translocation to the cytosol with diphtheria toxin as vector, EMBO J. 11:4835–4842.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Wu, J., Yang, J. T., and Wu, C. C. S., 1992, β-II conformation of all β-proteins can be distinguished from unordered structure by circular dichroism, Anal. Biochem. 200:359–364.

    Article  CAS  PubMed  Google Scholar 

  • Zhang, J., Cousens, L. S., Barr, P. J., and Sprang, S. R., 1991, Three-dimensional structure ot human basic fibroblast growth factor, a structural homolog of interleukin Iβ, Proc. Nail. Acad. Sci. USA 88:3446–3450.

    Article  CAS  Google Scholar 

  • Zhu, X., 1993, Structure-function studies of fibroblast growth factors (FGFs), Ph.D. thesis, California Institute of Technology, Pasadena, CA.

    Google Scholar 

  • Zhu, X., Hsu, B. T., and Rees, D. C., 1993, Structural studies of the binding of the anti-ulcer drug sucrose octasulfate to acidic fibroblast growth factor. Structure 1:27–34.

    Article  CAS  PubMed  Google Scholar 

  • Zhu, X., Komiya, H., Chirino, A., Faham, S., Fox, G. M., Arakawa, T., Hsu, B. T., and Rees, D. C., 1991, Three-dimensional structures of acidic and basic fibroblast growth factors. Science 251:90–93.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Vaccine Pharmaceutical Research, Merck Research Laboratories, West Point, Pennsylvania, 19486, USA

    David B. Volkin & C. Russell Middaugh

Authors
  1. David B. Volkin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Russell Middaugh
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Megabios Corporation, Burlingame, California, USA

    Rodney Pearlman

  2. Scios Nova, Inc., Mountain View, California, USA

    Y. John Wang

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Kluwer Academic Publishers

About this chapter

Cite this chapter

Volkin, D.B., Middaugh, C.R. (2002). The Characterization, Stabilization, and Formulation of Acidic Fibroblast Growth Factor. In: Pearlman, R., Wang, Y.J. (eds) Formulation, Characterization, and Stability of Protein Drugs: Case Histories. Pharmaceutical Biotechnology, vol 9. Springer, Boston, MA. https://doi.org/10.1007/0-306-47452-2_3

Download citation

  • DOI: https://doi.org/10.1007/0-306-47452-2_3

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-306-45332-8

  • Online ISBN: 978-0-306-47452-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation